Glaukos (GKOS) Free Cash Flow Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -27.72% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 77.20% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -20.37% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.32% |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 24.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.08% |
| Dec 31, 2025 | -33.06% |
| Sep 30, 2025 | 27.12% |
| Jun 30, 2025 | 24.97% |
| Mar 31, 2025 | -100.01% |
| Dec 31, 2024 | 70.99% |
| Sep 30, 2024 | -31.04% |
| Jun 30, 2024 | -5.85% |
| Mar 31, 2024 | -375.59% |
| Dec 31, 2023 | -44.86% |
| Sep 30, 2023 | 28.47% |
| Jun 30, 2023 | -0.67% |
| Mar 31, 2023 | -39.49% |
| Dec 31, 2022 | 66.56% |
| Sep 30, 2022 | -101.23% |
| Jun 30, 2022 | -87.27% |
| Mar 31, 2022 | 109.20% |
| Dec 31, 2021 | -93.61% |
| Sep 30, 2021 | 129.76% |
| Jun 30, 2021 | -96.98% |
| Mar 31, 2021 | 26.89% |
| Dec 31, 2020 | -7.26% |
| Sep 30, 2020 | -63.30% |
| Jun 30, 2020 | -87.09% |
| Mar 31, 2020 | -121.48% |
| Dec 31, 2019 | -85.24% |
| Sep 30, 2019 | -85.47% |
| Jun 30, 2019 | -3.09% |
| Mar 31, 2019 | 30.40% |
| Dec 31, 2018 | 129.59% |
| Sep 30, 2018 | 90.49% |
| Jun 30, 2018 | 78.20% |
| Mar 31, 2018 | -95.33% |
| Dec 31, 2017 | 99.62% |
| Sep 30, 2017 | 102.65% |
| Jun 30, 2017 | 156.78% |